Effect of metformin on diastolic heart failure in diabetic patient with ?diastolic heart failure
Phase 2
Recruiting
- Conditions
- Melitus diabetes.Diabetes mellitus due to underlying condition
- Registration Number
- IRCT20141209020258N69
- Lead Sponsor
- Arak University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 114
Inclusion Criteria
Not receiving metformin over the past 6 months
HbA1C less than 8/5
?Preserved EFor normal EF
Exclusion Criteria
Intolerance to metformin
DKA
GFR less than 30
systolic heart failure
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Determine the degree of diastolic failure. Timepoint: Initially and 4 months after starting treatment. Method of measurement: Ecocardiography.
- Secondary Outcome Measures
Name Time Method